Phosphorylation of nucleoside-metallacarborane and carborane conjugates by nucleoside kinases

Nucleosides, Nucleotides and Nucleic Acids

Volumn 32, Issue 10, 2013, Pages 571-588

  Wojtczak, Blazej A ^a,c   Olejniczak, Agnieszka B ^a   Wang, Liya ^b   Eriksson, Staffan ^b   Lesnikowski, Zbigniew J ^a  

^a INSTITUTE OF MEDICAL BIOLOGY   (Poland)

^b SWEDISH UNIVERSITY OF AGRICULTURAL SCIENCES   (Sweden)

^c UNIVERSITY OF WARSAW   (Poland)

Author keywords

Carborane; metallacarborane; nucleoside conjugates; nucleoside kinase; phosphorylation

Indexed keywords

BORON; CARBORANE DERIVATIVE; DEOXYNUCLEOSIDE KINASE; METALLACARBORANE; PHOSPHOTRANSFERASE; PURINE NUCLEOSIDE; PYRIMIDINE NUCLEOSIDE; THYMIDINE; THYMIDINE KINASE; THYMIDINE KINASE 1; THYMIDINE KINASE 2; TRIAZOLE; UNCLASSIFIED DRUG;

ARTICLE; CONJUGATE; CONTROLLED STUDY; DRUG STRUCTURE; DRUG SYNTHESIS; ENZYME SUBSTRATE; PROTEIN PHOSPHORYLATION;

BORON; HUMANS; MODELS, MOLECULAR; MOLECULAR CONFORMATION; NUCLEOSIDES; ORGANOMETALLIC COMPOUNDS; PHOSPHORYLATION; PHOSPHOTRANSFERASES;

EID: 84886070439     PISSN: 15257770     EISSN: 15322335     Source Type: Journal    
DOI: 10.1080/15257770.2013.838259     Document Type: Article

References (41)

1. Lesnikowski, Z.J. DNA as platform for new biomaterials. metal-containing nucleic acids. Curr. Org. Chem. 2007, 11, 355-381.
2. Lesnikowski, Z.J. Boron units as pharmacophores - new applications and opportunities of boron cluster chemistry. Coll. Czech. Chem. Commun. 2007, 72, 1646-1658.
3. Lesnikowski, Z.J. New Opportunities in Boron Chemistry for Medical Applications in Boron Science: New Technologies&Applications, ed. N.S. Hosmane, CRC Press-Taylor and Francis Group, Boca Raton, FL, 2011, pp. 3-19.
4. Issa, F.; Kassiou, M.; Rendina, L.M. Boron in drug discovery: carboranes as unique pharmacophores in biologically active compounds. Chem.Rev. 2011, 111, 5701-5722.
5. Scholz, M.; Hey-Hawkins, E. Carbaboranes as pharmacophores: properties, synthesis, and application strategies. Chem. Rev. 2011, 111, 7035-7062.
6. Lesnikowski, Z.J.; Shi, J.X.; Schinazi, R.F. Nucleosides containing carboranes. J. Organomet. Chem. 1999, 581, 156-169.
7. Bednarska, K.; Olejniczak, A.B.; Wojtczak, B.A.; Sulowska, Z.; Lesnikowski, Z.J. Adenosine and 2'- deoxyadenosine modified with boron cluster pharmacophores as new classes of human blood platelet function modulators. Chem. Med. Chem. 2010, 5, 749-756.
8. Bednarska, K.; Olejniczak, A.B.; Piskala, A.; Klink, M.; Sulowska, Z.; Lesnikowski, Z.J. Effect of adenosine modified with a boron cluster pharmacophore on reactive oxygen species production by human neutrophils. Bioorg.Med.Chem. 2012, 20, 6621-6629.
9. Barth, R.F.; Coderre, J.A.; Vicente, M.G.H.; Blue, T.E. Boron neutron capture therapy of cancer: current status and future prospects. Clin. Cancer Res. 2005, 11, 3987-4002.
10. Lesnikowski, Z.J.; Paradowska, E.;Olejniczak, A.B.; Studzinska, M.; Seekamp, P.; Schussler, U.; Gabel, D.; Schinazi, R.F.; Plesek, J. Towards new boron carriers for boron neutron capture therapy: metallacarboranes and their nucleoside conjugates. Bioorg. Med. Chem. 2005, 13, 4168-4175.
11. Hawthorne, M.F.; Maderna, A. Applications of radiolabeled boron clusters to the diagnosis and treatment of cancer. Chem.Rev. 1999, 99, 3421-3434.
12. Armstrong, A.F.; Valliant, J.F. The bioinorganic and medicinal chemistry of carboranes: from new drug discovery to molecular imaging and therapy. Dalton Trans. 2007, 4240-4251.
13. Olejniczak, A.B.; Corsini, M.; Fedi, S.; Zanello, P.; Lesnikowski, Z.J.Nucleoside-metallacarborane conjugates for multipotential electrochemical coding of DNA. Electrochem. Commun. 2007, 9, 1007-1011.
14. Schlawe, D.; Majdalani, A.; Velcicky, J.; Hessler, E.; Wieder, T.; Prokop, A.; Schmalz, H.G. Ironcontaining nucleoside analogues with pronounced apoptosis-inducing activity. Angew.Chem.Int.Ed Engl. 2004, 43, 1731-1734.
15. Jefries, F.J.; De Clercq, E. Antiviral Chemotherapy, John Wiley & Sons, Chichester, 1995.
16. Tjarks, W. The use of boron clusters in the rational design of boronated nucleosides for neutron capture therapy of cancer. J.Organomet.Chem. 2000, 614, 37-47.
17. Al-Madhoun, A.S.; Johnsamuel, J.; Barth, R.F.; Tjarks, W.; Eriksson, S. Evaluation of human thymidine kinase 1 substrates as new candidates for boron neutron capture therapy. Cancer Res. 2004, 64, 6280-6286.
18. Al-Madhoun, A.S.; Tjarks, W.; Eriksson, S. The role of thymidine kinases in the activation of pyrimidine nucleoside analogues. Min.-Rev. Med. Chem. 2004, 4, 341-350.
19. Tjarks, W.; Tiwari, R.; Byun, Y.; Narayanasamy, S.; Barth, R.F. Carboranyl thymidine analogues for neutron capture therapy. Chem.Commun. 2007, 4978-4991.
20. Eriksson, S.; Kierdaszuk, B.; Munch-Petersen, B.; Oberg, B.; Johansson, N.G. Comparison of the substrate specificities of human thymidine kinase 1 and 2 and deoxycytidine kinase toward antiviral and cytostatic nucleoside analogs. Biochem.Biophys.Res.Commun. 1991, 176, 586-592.
21. Barth, R.F.; Yang, W.; Wu, G.; Swindall, M.; Byun, Y.; Narayanasamy, S.; Tjarks, W.; Tordoff, K.; Moeschberger, M.L.; Eriksson, S.; Binns, P.J.; Riley, K.J. Thymidine kinase 1 as a molecular target for boron neutron capture therapy of brain tumors. Proc.Natl.Acad.Sci.U.S.A, 2008, 105, 17493-17497.
22. Olejniczak, A.B.; Plesek, J.; Lesnikowski, Z.J. Nucleoside- metallacarborane conjugates for basespecific metal labeling of DNA. Chem. Eur. J. 2007, 13, 311-318.
23. Olejniczak, A.; Wojtczak, B.; Lesnikowski, Z.J. 2'-deoxyadenosine bearing hydrophobic carborane pharmacophore. Nucl. Nucl. Nucleic Acids, 2007, 26, 1611-1613.
24. Wojtczak, B.A.; Andrysiak, A.; Gruner, B.; Lesnikowski, Z.J. "Chemical Ligation": a versatile method for nucleoside modification with boron clusters. Chem. Eur. J. 2008, 14, 10675-10682.
25. Byun, Y.; Yan, J.; Al-Madhoun, A.S.; Johnsamuel, J.; Yang, W.; Barth, R.F. Eriksson, S.; Tjarks, W. Synthesis and biological evaluation of neutral and zwitterionic 3-carboranyl thymidine analogues for boron neutron capture therapy. J.Med.Chem. 2005, 48, 1188-1198.
26. Bohman, C.; Eriksson, S. Deoxycytidine kinase from human leukemic spleen: preparation and characteristics of homogeneous enzyme. Biochemistry, 1988, 27, 4258-4265.
27. Munch-Petersen, B.; Cloos, L.; Tyrsted, G.; Eriksson, S. Diverging substrate specificity of pure human thymidine kinases 1 and 2 against antiviral dideoxynucleosides. J.Biol.Chem. 1991, 266, 9032-9038.
28. Lunato, A.J.; Wang, J.; Woollard, J.E.; Anisuzzaman, A.K.; Ji, W.; Rong, F.G.; Ikeda S.; Soloway, A.H.; Eriksson, S.; Ives, D.H.; Blue, T.E.; Tjarks, W. Synthesis of 5-(carboranylalkylmercapto)-2'- deoxyuridines and 3-(carboranylalkyl)thymidines and their evaluation as substrates for human thymidine kinases 1 and 2. J.Med.Chem. 1999, 42, 3378-3389.
29. Wang, L.; Karlsson, A.; Arner, E.S.; Eriksson, S. Substrate specificity of mitochondrial 2'- deoxyguanosine kinase. efficient phosphorylation of 2-chlorodeoxyadenosine. J.Biol.Chem. 1993, 268, 22847-22852.
30. Malmquist, J.; Sjoberg, S. Synthesis of P-carboranylalanine (p-Car) and 2-methyl-o-carboranylalanine (Me-o-Car). Tetrahedron, 1996, 52, 9207-9218.
31. Dagle, J.M.; Andracki, M.E.; DeVine, R.J.; Walder, J.A. Physical properties of oligonucleotides containing phosphoramidate-modified internucleoside linkages. Nucleic Acids Res. 1991, 19, 1805-1810.
32. Al-Madhoun, A.S.; Johnsamuel, J.; Yan, J.H.; Ji, W.H.; Wang, J.H.; Zhuo, J.C.; Lunato, A.J.; Woollard, J.E.; Hawk, A.E.; Cosquer, G.Y.; Blue, T.E.; Eriksson, S.; Tjarks, W. Synthesis of a small library of 3-(carboranylalkyl) thymidines and their biological evaluation as substrates for human thymidine kinases 1 and 2. J. Med. Chem. 2002, 45, 4018-4028.
33. Johnsamuel, J.; Lakhi, N.; Al-Madhoun, A.S.; Byun, Y.; Yan, J.; Eriksson, S. Tjarks, W. Synthesis of ethyleneoxide modified 3-carboranyl thymidine analogues and evaluation of their biochemical, physicochemical, and structural properties. Bioorg.Med.Chem. 2004, 12, 4769-4781.
34. Semioshkin, A.; Laskova, J.; Wojtczak, B.; Andrysiak, A.; Godovikov, I.; Bregadze, V.; Lesnikowski, Z.J. Synthesis of closo-dodecaborate based nucleoside conjugates. J. Organomet. Chem. 2009, 694, 1375-1379.
35. Malmquist, J.; Sjoberg, S. Synthesis of 2-[2-(3-aminopropyl)-1,2-dicarba- closo-dodecaboran(12)-1- ylmethoxy]-1,3-propanediol, a hydrophilically substituted aminoalkyl-o-carborane. Acta Chem.Scand. 1994, 48, 886-890.
36. Wilson, J.G.; Anisuzzaman, A.K.; Alam, F.; Soloway, A.H. Development of carborane synthons: synthesis and chemistry of (aminoalkyl)carboranes. Inorg.Chem. 1992, 31, 1955-1958.
37. Sabini, E.; Hazra, S.; Ort, S.; Konrad, M.; Lavie, A. Structural basis for substrate promiscuity of DCK. J.Mol.Biol. 2008, 378, 607-621.
38. Hakkarainen, J.J.; Pajander, J.; Laitinen, R.; Suhonen, M.; Forsberg, M.M. Similar molecular descriptors determine the in vitro drug permeability in endothelial and epithelial cell. Int. J. Pharm. 2012, 436, 426-443.
39. Agarwal, H.K.; McElroy, C.A.; Sjuvarsson, E.; Eriksson, S.; Darby, M.V.; Tjarks, W. Synthesis of N3- substituted carboranyl thymidine bioconjugates and their evaluation as substrates of recombinant human thymidine kinase 1. Eur.J.Med.Chem. 2013, 60, 456-468.
40. Deville-Bonnea, D.; El Amri, C.; Meyer, P.; Chen, Y.; Agrofoglio, L.A.; Janin, J. Human and viral nucleoside/ nucleotide kinases involved in antiviral drug activation: structural and catalytic properties. Antiviral Res. 2010, 86, 101-120.
41. Ciliberti, N.; Manfredini, S.; Angusti, A.; Durini, E.; Solaroli, N.; Vertuani, S.; Buzzoni, L.; Bonache, M.C.; Ben-Shalom, E.; Karlsson, A.; Saada, A.; Balzarini, J. Novel selective human mitochondrial kinase inhibitors: design, synthesis and enzymatic activity. Bioorg.Med.Chem. 2007, 15, 3065-3081.